Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp (NY: NVRO )

9.800 +0.260 (+2.73%)
Streaming Delayed Price Updated: 11:39 AM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nevro Corp

< Previous 1 2 3 4 Next >
Beyond The Numbers: 6 Analysts Discuss Nevro Stock
Via Benzinga
Assessing Nevro: Insights From 9 Financial Analysts
Via Benzinga
NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
Via AB Newswire
Where Nevro Stands With Analysts
Via Benzinga
Why Nevro Stock Lagged the Market on Thursday
Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments. 
Via The Motley Fool
Analyst Scoreboard: 4 Ratings For Nevro
Via Benzinga
Nevro: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
What Analysts Are Saying About Nevro Stock
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Nevro
Via Benzinga
Where Nevro Stands With Analysts
Via Benzinga
What 4 Analyst Ratings Have To Say About Nevro
Via Benzinga
Earnings Preview For Nevro
Via Benzinga
What 21 Analyst Ratings Have To Say About Nevro
Via Benzinga
Expert Ratings for Nevro
Via Benzinga
Why Shares of Nevro Are Down Wednesday
The medical device maker saw increased revenue, but earnings lagged estimates. 
Via The Motley Fool
Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates
Pain management company Nevro Corp (NASDAQ: NVRO) reported Q2 FY23 revenue of $108.8 million, up 4% Y/Y, missing the management guidance of $110 million-$112 million and  
Via Benzinga
What 17 Analyst Ratings Have To Say About Nevro
Via Benzinga
Uncertainties In Nevro's Core Business Lead To Revised FY24 Projections By Oppenheimer Analyst
Via Benzinga
Where Nevro Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
Via Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 61 companies hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.